| http://www.w3.org/ns/prov#value | - See, ?????? Surfactant Replacement Therapy for Respiratory Medicine ??? Cystic Fibrosis.??? We are conducting research and preclinical development with our KL4 surfactant potentially to address Acute Lung Injury (ALI), and, potentially in the future, other diseases associated with inflammation of the lung, such as Asthma and Chronic Obstructive Pulmonary Disease (COPD).
|
